HEU-EFS Launches Task 3.1.6 on Support and Reimbursement Conditions for Investigational Medical Devices

The HEU-EFS consortium has officially launched Task 3.1.6, bringing partners together to map support and reimbursement conditions for investigational medical devices across Europe.

This important activity represents a key step toward enabling more effective Early Feasibility Studies (EFS), supporting the uptake of medical innovation, and contributing to the enhancement of Europe’s competitiveness in the medtech sector.

Collaborative Leadership Across the Consortium

The task is jointly led by SDA Bocconi and Greater Paris University Hospitals – AP-HP, with contributions from partners across the HEU-EFS consortium.

By pooling expertise, knowledge, and resources from across the partnership, the consortium aims to build a comprehensive understanding of the current landscape and identify practical approaches to support innovation and patient access.

As the work progresses, HEU-EFS will continue sharing updates and insights from this important initiative.

Stay tuned for more developments in the coming months.